These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

123 related articles for article (PubMed ID: 2913186)

  • 1. Assessing methods for causality assessment of suspected adverse drug reactions.
    Hutchinson TA; Lane DA
    J Clin Epidemiol; 1989; 42(1):5-16. PubMed ID: 2913186
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Validation and Reproducibility of the Updated French Causality Assessment Method: an Evaluation by Pharmacovigilance Centres & Pharmaceutical Companies.
    Théophile H; Dutertre JP; Gérardin M; Valnet-Rabier MB; Bidault I; Guy C; Haramburu F; Hillaire-Buys D; Méglio C; Arimone Y
    Therapie; 2015; 70(5):465-76. PubMed ID: 26423144
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Agreement of expert judgment in causality assessment of adverse drug reactions.
    Arimone Y; Bégaud B; Miremont-Salamé G; Fourrier-Réglat A; Moore N; Molimard M; Haramburu F
    Eur J Clin Pharmacol; 2005 May; 61(3):169-73. PubMed ID: 15827761
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Causality assessment of adverse reactions to drugs--I. A novel method based on the conclusions of international consensus meetings: application to drug-induced liver injuries.
    Danan G; Benichou C
    J Clin Epidemiol; 1993 Nov; 46(11):1323-30. PubMed ID: 8229110
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Initial development and testing of an instrument for patient self-assessment of adverse drug reactions.
    Jarernsiripornkul N; Chaipichit N; Pratipanawatr T; Uchaipichat V; Krska J
    Pharmacoepidemiol Drug Saf; 2016 Jan; 25(1):54-63. PubMed ID: 26349635
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Can decisional algorithms replace global introspection in the individual causality assessment of spontaneously reported ADRs?
    Macedo AF; Marques FB; Ribeiro CF
    Drug Saf; 2006; 29(8):697-702. PubMed ID: 16872243
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Inter-expert agreement of seven criteria in causality assessment of adverse drug reactions.
    Arimone Y; Miremont-Salamé G; Haramburu F; Molimard M; Moore N; Fourrier-Réglat A; Bégaud B
    Br J Clin Pharmacol; 2007 Oct; 64(4):482-8. PubMed ID: 17711539
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Causality assessment in drug-induced liver injury.
    Hayashi PH
    Semin Liver Dis; 2009 Nov; 29(4):348-56. PubMed ID: 19826968
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Evaluation of naranjo adverse drug reactions probability scale in causality assessment of drug-induced liver injury.
    García-Cortés M; Lucena MI; Pachkoria K; Borraz Y; Hidalgo R; Andrade RJ;
    Aliment Pharmacol Ther; 2008 May; 27(9):780-9. PubMed ID: 18284654
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The surgeon general's "epidemiologic criteria for causality." A critique.
    Burch PR
    J Chronic Dis; 1983; 36(12):821-36. PubMed ID: 6655026
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Causality assessment in pharmacovigilance: The French method and its successive updates.
    Miremont-Salamé G; Théophile H; Haramburu F; Bégaud B
    Therapie; 2016 Apr; 71(2):179-86. PubMed ID: 27080836
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Interrater agreement of two adverse drug reaction causality assessment methods: A randomised comparison of the Liverpool Adverse Drug Reaction Causality Assessment Tool and the World Health Organization-Uppsala Monitoring Centre system.
    Mouton JP; Mehta U; Rossiter DP; Maartens G; Cohen K
    PLoS One; 2017; 12(2):e0172830. PubMed ID: 28235001
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Recognition and assessment of adverse drug reactions in children.
    Venulet J
    Bratisl Lek Listy; 1991 Nov; 92(11):540-3. PubMed ID: 1806164
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Validity of anecdotal reports of suspected adverse drug reactions: the problem of false alarms.
    Venning GR
    Br Med J (Clin Res Ed); 1982 Jan; 284(6311):249-52. PubMed ID: 6799125
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Can causality assessment fulfill the new European definition of adverse drug reaction? A review of methods used in spontaneous reporting.
    Mascolo A; Scavone C; Sessa M; di Mauro G; Cimmaruta D; Orlando V; Rossi F; Sportiello L; Capuano A
    Pharmacol Res; 2017 Sep; 123():122-129. PubMed ID: 28694146
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Aspects of standardization as applied to the assessment of drug-event associations.
    Venulet J
    Drug Inf J; 1984; 18(3-4):199-210. PubMed ID: 10268551
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Does proof of casualty ever exist in pharmacovigilance?
    Auriche M; Loupi E
    Drug Saf; 1993 Sep; 9(3):230-5. PubMed ID: 8240728
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Causality assessment for suspected DILI during clinical phases of drug development.
    Regev A; Seeff LB; Merz M; Ormarsdottir S; Aithal GP; Gallivan J; Watkins PB
    Drug Saf; 2014 Nov; 37 Suppl 1(Suppl 1):S47-56. PubMed ID: 25352327
    [TBL] [Abstract][Full Text] [Related]  

  • 19. MOdified NARanjo Causality Scale for ICSRs (MONARCSi): A Decision Support Tool for Safety Scientists.
    Comfort S; Dorrell D; Meireis S; Fine J
    Drug Saf; 2018 Nov; 41(11):1073-1085. PubMed ID: 29876835
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Identification of adverse reactions to new drugs. III: Alerting processes and early warning systems.
    Venning GR
    Br Med J (Clin Res Ed); 1983 Feb; 286(6363):458-60. PubMed ID: 6401562
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.